Mutations in FMN binding pocket diminish chromate reduction rates for Gh-ChrR isolated from Gluconacetobacter hansenii

Janin A. Khaleel, Chunhong Gong, Yanfeng Zhang, Ruimin Tan, Thomas C. Squier, Hongjun Jin

Fundamental & Computational Sciences Directorate, Pacific Northwest National Laboratory, Richland, USA.

DOI: 10.4236/ns.2013.56A003                

Abstract

A putative chromate ion binding site was identified proximal to a rigidly bound FMN from electron densities in the crystal structure of the quinone reductase from Gluconacetobacter hansenii (Gh-ChrR) (3s2y.pdb). To clarify the location of the chromate binding site, and to understand the role of FMN in the NADPH-dependent reduction of chromate, we have expressed and purified four mutant enzymes involving the site-specific substitution of individual side chains within the FMN binding pocket that form non-covalent bonds with the ribityl phosphate (i.e., S15A and R17A in loop 1 between β1 sheet and α1 helix) or the isoalloxanzine ring (E83A or Y84A in loop 4 between the β3 sheet and α4 helix). Mutations that selectively disrupt hydrogen bonds between either the N3 nitrogen on the isoalloxanzine ring (i.e., E83) or the ribitylphos- phoate (i.e., S15) respectively result in 50% or 70% reductions in catalytic rates of chromate reduction. In comparison, mutations that disrupt π-π ring stacking interactions with the isoal-loxanzine ring (i.e., Y84) or a salt bridge with the ribityl phosphate result in 87% and 97% inhibittion. In all cases there are minimal alterations in chromate binding affinities. Collectively, these results support the hypothesis that chromate binds proximal to FMN, and implicate a structural role for FMN positioning for optimal chromate reduction rates. As side chains proximal to the β3/α4 FMN binding loop 4 contribute to both NADH and metal ion binding, we propose a model in which structural changes around the FMN binding pocket couples to both chromate and NADH binding sites.

Keywords

Bioremediation; Chromate Reduction; Enzyme Redesign; Site-Specific Mutagenesis; Chromate Reductase; Flavin Mononucleotide; Promiscuous Enzyme Activities

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Ackerley, D.F., Gonzalez, C.F., Keyhan, M., Blake II, R. and Matin, A. (2004) Mechanism of chromate reduction by the Escherichia coli protein, NfsA, and the role of different chromate reductases in minimizing oxidative stress during chromate reduction. Environmental Microbiology, 6, 851-860. doi:10.1111/j.1462-2920.2004.00639.x
[2]	Ackerley, D.F., Gonzalez, C.F., Park, C.H., Blake II, R., Keyhan, M. and Matin, A. (2004) Chromate-reducing properties of soluble flavoproteins from Pseudomonas putida and Escherichia coli. Applied and Environmental Micro biology, 70, 873-882. doi:10.1128/AEM.70.2.873-882.2004
[3]	Gonzalez, C.F., Ackerley, D.F., Lynch, S.V. and Matin, A. (2005) ChrR, a soluble quinone reductase of Pseudomonas putida that defends against H2O2. Journal of Bio logical Chemistry, 280, 22590-22595. doi:10.1074/jbc.M501654200
[4]	Xiong, Y., Chen, B., Shi, L., Fredrickson, J.K., Bigelow, D.J. and Squier, T.C. (2011) Targeted protein degradation of outer membrane decaheme cytochrome MtrC metal reductase in Shewanella oneidensis MR-1 measured using biarsenical probe CrAsH-EDT(2). Biochemistry, 50, 9738-9751. doi:10.1021/bi200602f
[5]	Shi, L., Squier, T.C., Zachara, J.M. and Fredrickson, J.K. (2007) Respiration of metal (hydr)oxides by Shewanella and Geobacter: A key role for multihaem c-type cytochromes. Molecular Microbiology, 65, 12-20. doi:10.1111/j.1365-2958.2007.05783.x
[6]	Xiong, Y., Shi, L., Chen, B., Mayer, M.U., Lower, B.H., Londer, Y., Bose, S., Hochella, M.F., Fredrickson, J.K. and Squier, T.C. (2006) High-affinity binding and direct electron transfer to solid metals by the Shewanella oneidensis MR-1 outer membrane c-type cytochrome OmcA, Journal of the American Chemical Society, 128, 13978-13979. doi:10.1021/ja063526d
[7]	Shi, L., Chen, B., Wang, Z., Elias, D.A., Mayer, M.U., Gorby, Y.A., Ni, S., Lower, B.H., Kennedy, D.W., Wunschel, D.S., Mottaz, H.M., Marshall, M.J., Hill, E.A., Beliaev, A.S., Zachara, J.M., Fredrickson, J.K. and Squier, T.C. (2006) Isolation of a high-affinity functional protein complex between OmcA and MtrC: Two outer membrane decaheme c-type cytochromes of Shewanella oneidensis MR-1. Journal of Bacteriology, 188, 4705-4714. doi:10.1128/JB.01966-05
[8]	Jin, H., Zhang, Y., Buchko, G.W., Varnum, S.M., Robin son, H., Squier, T.C. and Long, P.E. (2012) Structure de termination and functional analysis of a chromate reducetase from Gluconacetobacter hansenii. PLoS One, 7, Article ID: e42432. doi:10.1371/journal.pone.0042432
[9]	Gonzalez, C.F., Ackerley, D.F., Park, C.H. and Matin, A. (2003) A soluble flavoprotein contributes to chromate re duction and tolerance by Pseudomonas putida. Acta Biotechnologica, 23, 233-239. doi:10.1002/abio.200390030
[10]	Park, C.H., Keyhan, M., Wielinga, B., Fendorf, S. and Matin, A. (2000) Purification to homogeneity and characterization of a novel Pseudomonas putida chromate reductase. Applied and Environmental Microbiology, 66, 1788-1795. doi:10.1128/AEM.66.5.1788-1795.2000
[11]	Barak, Y., Ackerley, D.F., Dodge, C.J., Banwari, L., Alex, C., Francis, A.J. and Matin, A. (2006) Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution. Applied and Environmental Microbiology, 72, 7074-7082. doi:10.1128/AEM.01334-06
[12]	Barak, Y., Thorne, S.H., Ackerley, D.F., Lynch, S.V., Con tag, C.H. and Matin, A. (2006) New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution. Molecular Cancer Therapeutics, 5, 97-103. doi:10.1158/1535-7163.MCT-05-0365
[13]	Eswaramoorthy, S., Poulain, S., Hienerwadel, R., Bre mond, N., Sylvester, M.D., Zhang, Y.B., Berthomieu, C., Van Der Lelie, D. and Matin, A. (2012) Crystal structure of ChrR—A quinone reductase with the capacity to re duce chromate. PLoS One, 7, Article ID: e36017. doi:10.1371/journal.pone.0036017
[14]	Thorne, S.H., Barak, Y., Liang, W., Bachmann, M.H., Rao, J., Contag, C.H. and Matin, A. (2009) CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy. Molecular Cancer Therapeutics, 8, 333-341. doi:10.1158/1535-7163.MCT-08-0707
[15]	Liger, D., Graille, M., Zhou, C.Z., Leulliot, N., Quevillon-Cheruel, S., Blondeau, K., Janin, J. and van Tilbeurgh, H. (2004) Crystal structure and functional characterization of yeast YLR011wp, an enzyme with NAD(P)H FMN and ferric iron reductase activities. Journal of Bio logical Chemistry, 279, 34890-34897. doi:10.1074/jbc.M405404200
[16]	Drennan, C.L., Pattridge, K.A., Weber, C.H., Metzger, A.L., Hoover, D.M. and Ludwig, M.L. (1999) Refined structures of oxidized flavodoxin from Anacystis nidulans. Journal of Molecular Biology, 294, 711-724. doi:10.1006/jmbi.1999.3151